| Literature DB >> 35755292 |
Ying Liu1,2, Yu Han3, Shizhu Chen4, Jingjie Liu2, Dajiang Wang2, Yifei Huang2.
Abstract
Photothermal therapy has the characteristics of minimal invasiveness, controllability, high efficiency, and strong specificity, which can effectively make up for the toxic side effects and tumor resistance caused by traditional drug treatment. However, due to the limited tissue penetration of infrared light, it is difficult to promote and apply in clinical practice. The eye is the only transparent tissue in human, and infrared light can easily penetrate the eye tissue, so it is expected that photothermal therapy can be used to treat fundus diseases. Here in, a new nano-platform assembled by liposome and indocyanine green (ICG) was used to treat retinoblastoma. ICG was assembled in liposomes to overcome some problems of ICG itself. For example, ICG is easily quenched, self-aggregating and instability. Moreover, liposomes can prevent free ICG from being cleared through the systemic circulation. The construction of the nano-platform not only ensured the stability of ICG in vivo, but also realized imaging-guide photothermal therapy, which created a new strategy for the treatment of retinoblastoma.Entities:
Keywords: ARVO, Association for Research in Vision and Ophthalmology; DLS, dynamic light scattering; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DSPE-PEG2000, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-2000]; EE, encapsulation efficiency; FL, fluorescence; H&E, hematoxylin‒eosin; ICG, indocyanine green; ILP, ICG-loaded liposomes; Imaging-guided; LP, Liposomes; Liposomes; Nanoplatform; PA, photoacoustic; PBS, phosphate-buffered saline; PDT, photodynamic therapy; PDTX, patient-derived tumor xenograft; PTT, photothermal therapy; Photothermal therapy; Rb, retinoblastoma; Retinoblastoma; TEM, transmission electron microscopy
Year: 2021 PMID: 35755292 PMCID: PMC9214327 DOI: 10.1016/j.apsb.2021.10.009
Source DB: PubMed Journal: Acta Pharm Sin B ISSN: 2211-3835 Impact factor: 14.903
Figure 1Characterization of ILP. Transmission electron microscope images of LP (A) and ILP (B). Hydrodynamic diameter of LP (C) and ILP (D). (E) Zeta potential and encapsulation efficiency of ILP. (F) The stability of ILP store in PBS over a period of month. (G) UV–vis absorption spectra and (H) the fluorescence spectra free ICG and ILP. (I) The temperature variation and (J) highest-temperature infrared thermal images of PBS, ICG and ILP after exposure under an 808 nm laser (1.5 W).
Figure 2Cellular uptake of ILP and LP. (A) and (B) The statistical graph of the fluorescence intensity (A) for Y79 cells and (B) for WERI-Rb-1 cells. (C) and (D) Flow cytometric analysis of the cellular uptake of free ICG and ILP by Y79 cell (C) and WERI-Rb-1 cell (D) at 4 h. (E) The fluorescence intensity of the cellular uptake of ICG and ILP at 4 h.
Figure 3Evaluation of the fluorescence and photoacoustic imaging capacity of ILP. (A) In vivo fluorescence and photoacoustic images of ICG and ILP at different time points. (B) and (C) Quantitative analysis of fluorescent intensity (B) and photoacoustic intensity (C) of tumor tissue. (D) Ex vivo fluorescence images of ICG and ILP at 6 h. (E) Quantitative analysis of fluorescent intensity of different tissue at 6 h.
Figure 4In vivo antitumor study. (A) and (B) Photographs (A) and temperature trend (B) of in vivo photothermal therapy at different time points. (C)‒(E) Tumor volume (C), body weight (D) and survival rate (E) of mice after treatment in all groups. (F) and (G) Photographs (F) and tumor weight (G) of isolated tumor tissue after treatment in all groups.
Figure 5In vivo antitumor study. (A) H&E stained images of the heart, liver, spleen, lung, and kidney from the mice in all group. (B) H&E stained images of the tumor from the mice in all groups. (C) Blood biochemical tests of mice after treatment.